B. Riley analyst Mayank Mamtani lowered the firm’s price target on Lineage Cell Therapeutics (LCTX) to $3 from $4 and keeps a Buy rating on the ...
In a regulatory filing, Analog Devices (ADI) disclosed that its CEO Vincent Roche sold 10K shares of common stock on March 12th in a total ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback